Status | Study |
Completed |
Study Name: The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil Condition: Benign Prostatic Hyperplasia Pupil Anomaly Date: 2017-05-02 Interventions: Drug: Alfuzosin Hydrochloride 10 MG |
Not yet recruiting |
Study Name: Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis Condition: Uveitis Uveitis, Posterior Uveitis, Anterior Date: 2017-03-27 Interventions: Combination Product: 4mg CLS-TA Suprachoriodal Injection CLS-TA, 4 mg in 100 microliters, will be admini |
Recruiting |
Study Name: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301 Condition: Uveitis Uveitis, Posterior Uveitis, Anterior Date: 2016-10-31 |
Recruiting |
Study Name: Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization Condition: Choroidal Neovascularization Date: 2016-08-21 Interventions: Drug: 0.5mg intravitreal ranibizumab Patients received ranibizumab (0.5mg, Novartis AG, Basel, Switzerla |
Recruiting |
Study Name: Intravitreal Conbercept for Idiopathic Choroidal Neovascularization Condition: Idiopathic Choroidal Neovascularization Date: 2016-07-27 Interventions: Drug: conbercept 0.05ml conbercept Other Name: conbe |
Recruiting |
Study Name: Advanced OCT and Adaptive Optics Imaging in Retinal Disease (The ACAD Study) Condition: Vitreous Diseases Retinal Diseases C Date: 2016-07-06 Interventions: Device: Swept-source optical coherence tomography (SS-OCT) |
Active, not recruiting |
Study Name: A Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the Eye Condition: Posterior Uveitis Intermediate Uveitis Panuveitis Date: 2016-04-19 Interventions: Drug: FAI insert |
Active, not recruiting |
Study Name: Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects With Chronic Non-infectious Posterior Uveitis Condition: Posterior Uveitis Intermediate Uveitis Panuveitis Date: 2016-04-19 Interventions: Drug: Sham Injection Drug: FAI Insert |
Recruiting |
Study Name: Micropulse 577nm Laser vs Traditional Laser Treatment in Central Serous Chorioretinopathy Condition: Central Serous Choroidopathy Date: 2016-03-16 Interventions: Device: 577-MPL 160 micron spo |
Recruiting |
Study Name: Study Evaluating the Efficacy of Aflibercept for the Treatment of Inflammatory CNV in Young Patients (ALINEA). Condition: Inflammatory Choroidal Neovascularization Date: 2015-09-18 Interventions: Drug: Aflibercept The patients are followed on a monthly basis until 52 weeks. Intravitreal injections o |